Pediatr Infect Vaccine.  2018 Aug;25(2):82-90. 10.14776/piv.2018.25.e3.

Bacterial Infections after Liver Transplantation in Children: Single Center Study for 16 Years

Affiliations
  • 1Department of Pediatrics, Seoul National University Hospital, Seoul, the Republic of Korea. pedwilly@snu.ac.kr
  • 2Department of Pediatrics, Seoul National University College of Medicine, Seoul, the Republic of Korea.
  • 3Department of General Surgery, Seoul National University Hospital, Seoul, the Republic of Korea.
  • 4Department of General Surgery, Seoul National University College of Medicine, Seoul, the Republic of Korea.

Abstract

PURPOSE
Survival after liver transplantation (LT) has improved over the years, but infection is still a major complication. We aimed to identify the characteristics of bacterial infections in pediatric LT recipients.
METHODS
This study is a retrospective review of 189 consecutive children undergoing LT between 2000 and 2015 at a single center. In this study, the incidence of infection was determined for the following periods: within 1 month, between 1-5 months, and between 6-12 months. Patients who underwent liver transplants more than once or multiple organ transplants were excluded.
RESULTS
All patients had received postoperative antibiotic for 3 days. Only the maintenance immunosuppression with oral tacrolimus and steroids were performed. As a result, 132 bacterial infections developed in 87 (46.0%) patients (0.70 events per person-year). Bacterial infections occurred most frequently within the first month (n=84, 63.6%) after LT. In the pathogens, Staphylococcus aureus (15.2%), Enterococcus species (15.2%), and Klebsiella species (13.6%) were most common. Regarding the organ infected, bloodstream was most common (n=39, 29.5%), followed by peritoneum (n=28, 21.2%), urinary tract (n=25, 18.9%), and lungs (n=20, 15.2%). We changed prophylactic antibiotics from ampicillin-sulbactam to piperacillin-tazobactam at 2011, October, there were no significant effects in the prevalence of antibiotics resistant bacterial infections. The 1-year mortality was 9.0% (n=17), in which 41.2% (n=7) was attributable to bacterial infection; septicemia (n=4), pneumonia (n=2), and peritonitis (n=1).
CONCLUSIONS
The incidence and type of bacterial infectious complications after LT in pediatric patients were similar to those of previous studies. Bacterial complications affecting mortality occur within 6 months after transplantation, so proper prophylaxis and treatment in this period may improve the prognosis of LT.

Keyword

Liver transplantation; Child; Bacterial infections; Korea

MeSH Terms

Anti-Bacterial Agents
Bacterial Infections*
Child*
Enterococcus
Humans
Immunosuppression
Incidence
Klebsiella
Korea
Liver Transplantation*
Liver*
Lung
Mortality
Peritoneum
Peritonitis
Pneumonia
Prevalence
Prognosis
Retrospective Studies
Sepsis
Staphylococcus aureus
Steroids
Tacrolimus
Transplants
Urinary Tract
Anti-Bacterial Agents
Steroids
Tacrolimus

Figure

  • Fig. 1 Number of deaths caused by bacterial infections.

  • Fig. 2 Proportion of gram-positive and gram-negative bacteria isolated from liver transplantation recipients, 2000 to 2015.


Reference

1. Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol. 2006; 5:77–85.
Article
2. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl. 2004; 10:886–897.
Article
3. Bucuvalas JC, Ryckman FC. Long-term outcome after liver transplantation in children. Pediatr Transplant. 2002; 6:30–36.
Article
4. Colombani PM, Dunn SP, Harmon WE, Magee JC, McDiarmid SV, Spray TL. Pediatric transplantation. Am J Transplant. 2003; 3:Suppl 4. 53–63.
Article
5. D'Alessandro AM, Knechtle SJ, Chin LT, Fernandez LA, Yagci G, Leverson G, et al. Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin. Pediatr Transplant. 2007; 11:661–670.
6. Ryckman FC, Alonso MH, Bucuvalas JC, Balistreri WF. Long-term survival after liver transplantation. J Pediatr Surg. 1999; 34:845–850.
Article
7. Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis. 1995; 21:1077–1091.
Article
8. Kim JE, Oh SH, Kim KM, Choi BH, Kim DY, Cho HR, et al. Infections after living donor liver transplantation in children. J Korean Med Sci. 2010; 25:527–531.
Article
9. Shoji K, Funaki T, Kasahara M, Sakamoto S, Fukuda A, Vaida F, et al. Risk factors for bloodstream infection after living-donor liver transplantation in children. Pediatr Infect Dis J. 2015; 34:1063–1068.
Article
10. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine (Baltimore). 1988; 67:132–143.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16:128–140.
Article
12. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007; 357:2601–2614.
Article
13. Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation--part I. Liver Transpl. 2005; 11:1452–1459.
Article
14. Shepherd RW, Turmelle Y, Nadler M, Lowell JA, Narkewicz MR, McDiarmid SV, et al. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant. 2008; 8:396–403.
Article
15. García S, Roque J, Ruza F, González M, Madero R, Alvarado F, et al. Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation: a study of 176 transplants. Clin Transplant. 1998; 12:190–197.
16. Fulginiti VA, Scribner R, Groth CG, Putnam CW, Brettschneider L, Gilbert S, et al. Infections in recipients of liver homografts. N Engl J Med. 1968; 279:619–626.
Article
17. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl. 2004; 10:844–849.
Article
18. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA. Causes of death in autopsied liver transplantation patients. Mod Pathol. 1998; 11:37–46.
19. Bubak ME, Porayko MK, Krom RA, Wiesner RH. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology. 1991; 14:1063–1065.
Article
20. Kim YJ, Kim SI, Wie SH, Kim YR, Hur JA, Choi JY, et al. Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience. Transpl Infect Dis. 2008; 10:316–324.
Article
Full Text Links
  • PIV
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr